These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7488690)

  • 21. Dexfenfluramine as an adjunct to a reduced-fat, ad libitum diet: effects on body composition, nutrient intake and cardiovascular risk factors.
    Swinburn BA; Carmichael HE; Wilson MR
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):1033-40. PubMed ID: 8923161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity].
    Liebermeister H; Probst G; Jahnke K
    Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324
    [No Abstract]   [Full Text] [Related]  

  • 23. Zonisamide for weight loss in obese adults: a randomized controlled trial.
    Gadde KM; Franciscy DM; Wagner HR; Krishnan KR
    JAMA; 2003 Apr; 289(14):1820-5. PubMed ID: 12684361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects.
    Cercato C; Roizenblatt VA; Leança CC; Segal A; Lopes Filho AP; Mancini MC; Halpern A
    Int J Obes (Lond); 2009 Aug; 33(8):857-65. PubMed ID: 19564877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes.
    Kaukua JK; Pekkarinen TA; Rissanen AM
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):600-5. PubMed ID: 14770192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a high-protein/low carbohydrate versus a standard hypocaloric diet on adipocytokine levels and insulin resistance in obese patients along 9 months.
    de Luis DA; Izaola O; Aller R; de la Fuente B; Bachiller R; Romero E
    J Diabetes Complications; 2015; 29(7):950-4. PubMed ID: 26166555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment with fenfluramine in obese subjects.
    Sensi S; Della Loggia F; Del Ponte A; Guagnano MT
    Int J Clin Pharmacol Res; 1985; 5(4):247-53. PubMed ID: 4055167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
    Sabuncu T; Ucar E; Birden F; Yasar O
    Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity--to treat or not to treat.
    Douglas JG; Ford MJ; Munro JF
    Scott Med J; 1979 Jan; 24(1):72-5. PubMed ID: 493935
    [No Abstract]   [Full Text] [Related]  

  • 31. d-fenfluramine treatment of binge eating disorder.
    Stunkard A; Berkowitz R; Tanrikut C; Reiss E; Young L
    Am J Psychiatry; 1996 Nov; 153(11):1455-9. PubMed ID: 8890680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.
    Astell KJ; Mathai ML; McAinch AJ; Stathis CG; Su XQ
    Complement Ther Med; 2013 Jun; 21(3):180-9. PubMed ID: 23642949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
    Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin sensitivity determines the effectiveness of dietary macronutrient composition on weight loss in obese women.
    Cornier MA; Donahoo WT; Pereira R; Gurevich I; Westergren R; Enerback S; Eckel PJ; Goalstone ML; Hill JO; Eckel RH; Draznin B
    Obes Res; 2005 Apr; 13(4):703-9. PubMed ID: 15897479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM;
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical trial of fenfluramine.
    Traherne JB
    Practitioner; 1965 Nov; 195(169):677-80. PubMed ID: 5321366
    [No Abstract]   [Full Text] [Related]  

  • 37. Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over.
    Fanghänel G; Cortinas L; Sánchez-Reyes L; Berber A
    Int J Obes Relat Metab Disord; 2001 May; 25(5):741-7. PubMed ID: 11360159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity.
    Aronne LJ
    Med Clin North Am; 1998 Jan; 82(1):161-81. PubMed ID: 9457156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New treatment for obesity: dexfenfluramine (Redux).
    Bihm B
    Medsurg Nurs; 1996 Oct; 5(5):360-2, 373. PubMed ID: 8981871
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacological treatment of obesity. Drugs with predominantly anorectic action].
    Ortensio A; Avagnina S; Costantino A
    Minerva Dietol Gastroenterol; 1988; 34(2):109-16. PubMed ID: 3050610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.